PD-031 An exploratory study-level meta-analysis assessing the impact of early tumour shrinkage on overall survival in patients with RAS wild-type metastatic colorectal cancer recei...

Autor Rivera, F., Karthaus, M., Valladares-Ayerbes, M., Gallego, J., Koukakis, R., Demonty, G., Douillard, J.-Y.
Vydáno v Ann Oncol (2016)

PD-026 Survival outcomes in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) classified by Köhne prognostic category and BRAF mutation status: retrospective ana...

Autor Köhne, C.-H., Rivera, F., Taieb, J., Siena, S., Peeters, M., Koukakis, R., Demonty, G., Douillard, J.-Y.
Vydáno v Ann Oncol (2016)

PD-028 Retrospective analysis of impact of Köhne prognostic category and BRAF mutation status on survival in patients with RAS wild-type metastatic colorectal cancer treated with s...

Autor Peeters, M., Siena, S., Douillard, J.-Y., Rivera, F., Taieb, J., Koukakis, R., Demonty, G., Köhne, C.-H.
Vydáno v Ann Oncol (2016)

Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Or...

Autor Witteveen, P. O., van der Velden, J., Vergote, I., Guerra, C., Scarabeli, C., Coens, C., Demonty, G., Reed, N.
Vydáno 2009

P-149 Impact of sequence of biologic therapies on overall survival (OS) in patients with RAS wild-type (WT) metastatic colorectal carcinoma (mCRC): an exploratory, retrospective po...

Autor Sobrero, A., Douillard, J.-Y., Rivera, F., Forget, F., Karthaus, M., Valladares-Ayerbes, M., Demonty, G., Guan, X., Peeters, M.
Vydáno v Ann Oncol (2016)

PD-024 Retrospective analysis of quality of life and early tumour shrinkage during first-line FOLFOX4 ± panitumumab in RAS wild-type metastatic colorectal carcinoma

Autor Siena, S., Tabernero, J., Bodoky, G., Cunningham, D., Rivera, F., Ruff, P., Canon, J.-L., Koukakis, R., Demonty, G., Douillard, J.-Y.
Vydáno v Ann Oncol (2016)